Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
RoosterBio
Sort By
Newest First
1 / 1
1 / 1
Cell Therapy Manufacturing
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
AGC Biologics
PR-M08-22-03
August 16, 2022
Regenerative Medicine
NFTs Are Bringing the Regenerative Medicine Community Together
Danielle Alvarez
Pharma's Almanac
PAO-05-022-CL-07
May 23, 2022
Mesenchymal Stem Cells
A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-022-CL-05
April 21, 2022
Mesenchymal Stem Cells
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-21-NI-01
March 12, 2022
Mesenchymal Stem Cells
Moving Beyond the Industrialization of MSCs
Tim Kelly, Ph.D.
RoosterBio
PAO-12-21-CL-06
March 12, 2022
Regenerative Medicine
Accelerating Innovation in Regenerative Medicine
RoosterBio
PAO-02-22-R250-04
February 03, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734
December 20, 2021
Cell Therapy
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
Ashish Patel, Ph.D.
The National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC)
PAO-09-21-CL-13
September 29, 2021
Gene Editing
Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-21-CL-06
July 15, 2021
